Skip to search formSkip to main contentSkip to account menu

Adenocarcinoma, Endometrioid

Known as: Adenocarcinomas, Endometrioid, Endometrioid Adenocarcinoma, Endometrioid Adenocarcinomas 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Carcinoma, Endometrioid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high‐grade serous carcinoma
Clear cell carcinoma (CCC) of the ovary is an uncommon, but an aggressive epithelial ovarian cancer (EOC), which has overlapping… 
2016
2016
The clinical significance of K-ras mutation in endometrial "surface epithelial changes" and their associated endometrial adenocarcinoma.
2015
2015
Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression
To understand the role of and differences in molecular alterations between endometrial and ovarian endometrioid adenocarcinomas. 
2011
2011
Loss of RKIP expression during the carcinogenic evolution of endometrial cancer
Aims Endometrial cancer is one of the most common cancers in women worldwide, but there is a lack of diagnostic markers for early… 
2011
2011
Inhibin-βA subunit immunolabeling as a prognostic factor in endometrioid adenocarcinomas: a matter of evaluation?
IntroductionInhibins and activins are secreted polypeptides of the transforming growth factor-β superfamily that comprise a… 
2009
2009
Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1
BackgroundHypoxia-inducible factor-1 (HIF-1) is an essential transcription factor that mediates cellular and systemic homeostatic… 
2007
2007
Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.
BACKGROUND AND AIM Altered mucin 1 (MUC1) secretion patterns have been implicated in several cancerous conditions including… 
Highly Cited
2007
Highly Cited
2007
Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer.
We previously reported that indoleamine-2,3-dioxygenase (IDO) is associated with paclitaxel resistance and that IDO serves as a… 
2007
2007
Serum p53 antibody as a diagnostic marker of high-risk endometrial cancer.
Highly Cited
1996
Highly Cited
1996
The immunohistochemical discrimination of endometrioid adenocarcinomas.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)